SLVM:NYSESylvamo Corporation Analysis
Data as of 2026-09-04 - not real-time
$35.93
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
At $35.92, Sylvamo Corporation shows a bearish moving-average alignment, with shorter averages beneath longer ones. Across the trailing 30 sessions it lost 6.1%. RSI sits at 43.3, which reads as neutral, and MACD momentum is bearish. The recent range runs from support at $34.25 up to resistance at $41.10.
Valuation screens as undervalued, on a P/E of 19.2 with no clean sector comparison available. Sell-side targets cluster 42.7% above the current quote.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 41.1%, a beta of 0.69 and a maximum drawdown of 36.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 1 out of 10.
Valuation screens as undervalued, on a P/E of 19.2 with no clean sector comparison available. Sell-side targets cluster 42.7% above the current quote.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 41.1%, a beta of 0.69 and a maximum drawdown of 36.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 1 out of 10.
Top Market Events
Sylvamo Corporation NYSE:SLVM reported weaker-than-expected second-quarter earnings on Friday, with both profit and...MEMPHIS, Tenn., August 07, 2026--Sylvamo NYSE: SLVM , the world’s paper company, is releasing second quarter...Sylvamo SLVM delivered earnings and revenue surprises of +121.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 43.00
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 43.00
- Analyst targets imply +42.7% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Analyst targets imply +42.7% versus the current price
- Negative free cash flow
- P/E ratio of 19.2
Key Metrics & Analysis
Financial Health
Revenue Growth1.50%
Profit Margin2.31%
P/E Ratio19.2
ROE7.94%
ROA4.33%
Debt/Equity107.96
P/B Ratio1.5
Op. Cash Flow$209.0M
Free Cash Flow$-16375000
Technical Analysis
TrendBearish
RSI43.3
Support$34.25
Resistance$41.10
MA 20$37.05
MA 50$37.82
MA 200$43.00
MACDBearish
VolumeDecreasing
Fear & Greed Index96.27
Valuation
Fair Value$26.73
Target Price$51.25
Upside/Downside42.66%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.69
Volatility41.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
ZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKWTS
Watts Water Technologies, Inc.
STOCKAMZN
Amazon.com, Inc.
STOCKBLK
BlackRock, Inc.
STOCKUSFD
US Foods Holding Corp.
STOCKUSAC
USA Compression Partners, LP
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.